Topical Vapocoolant Quickly and Effectively Reduces Vaccine-associated Pain: Results of a Randomized, Single-blinded, Placebo-controlled Study
|
|
- Ashley Byrd
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLES Topical Vapocoolant Quickly and Effectively Reduces Vaccine-associated Pain: Results of a Randomized, Single-blinded, Placebo-controlled Study Steven Mawhorter, Lynda Daugherty,Allison Ford, Robin Hughes, Dee Metzger, and Kirk Easley Background: Comprehensive international travel preparation often requires several vaccines. Up to 90% of adults have some fear of injections, mostly due to injection-related pain. Pediatric studies with routine vaccines have shown topical anesthetic EMLA cream (lidocaine and prilocaine, Astra Pharmaceuticals, Inc.) and the topical vapocoolant Fluori-Methane (dichlorodifluoromethane and trichlorodifluoromethane, Gebauer Co.) to be equally effective in reducing pain from vaccinations. EMLA cream is expensive and requires a 60-min application, while Fluori-Methane (FM) is immediate in onset of action and inexpensive. Skin anesthesia begins at 10 C. Fluori-Methane can briefly cool the skin to 0 C. Methods: We studied the effectiveness of topical vapocoolant on adult clients at our international travel clinic in a randomized, controlled trial of topical FM vs. cold (4 C) saline placebo. Using a preset randomization table, participants served as their own controls, receiving placebo/control or active agent (participant blinded) in one arm (left or right), and a similar number of vaccines in the untreated arm. Vaccines were administered according to a set protocol per arm to minimize the risk of bias. Pain was measured using a modified McGill present pain intensity (PPI) pain index. Subjects rated their pain immediately and at 5 min on a six-level scale, noting treated and untreated arms separately. A questionnaire was completed on intervention preferences. Sample size was predetermined to achieve 90% statistical power estimating 25% efficacy (minimum n 172). Results: One hundred and eighty-five participants were enrolled; 93 FM and 92 cold saline placebo. FM-treated arms had a significant reduction in immediate pain compared to untreated arms (pain scale mean 2.2 vs. 3.1; p.0001), and compared to placebo (mean 2.2 vs. 2.8; p.01). Delayed pain at 5 min was not affected by FM or control (mean 1.9 vs. 2.0) compared to no intervention (pain scale 1.9). The intervention preference questionnaire indicated that participants did not find FM therapy uncomfortable. They would choose FM therapy in the future, over a cream, especially if a wait was involved. Conclusion: The topical vapocoolant Fluori-Methane is an effective, quick, preferred, inexpensive agent for reducing vaccineassociated injection pain for international travel clients. Steven Mawhorter, MD, DTM&H, Lynda Daugherty, RN, Allison Ford, Robin Hughes, RN, and Dee Metzger, RN: Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH; Kirk Easley, MS, M Ap Stat: Department of Biostatistics, Emory University, Atlanta, GA. This work was presented in part at the American Society of Tropical Medicine and Hygiene 50th Annual Meeting, Abstract Atlanta, GA, November Reprint requests: Steven D. Mawhorter, MD, DTM&H, Cleveland Clinic Foundation, Department of Infectious Diseases/S32, 9500 Euclid Avenue, Cleveland, OH J Travel Med 2004; 11: Travel from the US to developing countries continues to grow. World Tourism Organization data indicate a 50% increase in international travel in each of the last several decades. 1 In 2000, nearly 40 million North Americans traveled to a developing country. 2 Travel to a developing country destination presents infectious risks due to highly variable sanitation practices, and local significant infectious diseases for which most travelers have no background immunity. Healthy international travel often requires multiple vaccinations. 3 Although not commonly discussed in the adult literature, the pain of immunizations is a recognized barrier to their acceptance in pediatric practice. 4,5 When surveyed, 21% to 90% of adults expressed some anxiety about the pain associated with needle-based 267
2 268 Journal of Travel Medicine, Volume 11, Number 5 procedures. 6,7 Up to 90% of young children show serious distress during vaccination. 8 This general level of anxiety can be severe in approximately 3.5% of Americans, and is termed injection phobia. 9 While minimized by some, this phobia can result in syncopal attacks with significant clinical impact. 10,11 Moreover, anxiety at any level can enhance pain perception, and analgesia interventions are designed to reduce both pain and anxiety The topical anesthetic cream EMLA (eutectic mixture of lidocaine and prilocaine, Astra Pharmaceuticals, Westborough, MA) is approved for use to reduce the pain of procedures including injections Limitations to the use of EMLA cream are 60-min delayed onset of anesthesia, and expense (approximately US $5.00 to $7.50 per dose). 14 As early as 1955,a volatile refrigerant liquid (ethyl chloride a vapocoolant spray) was shown to produce cutaneous anesthesia. The agent works by reducing skin temperature to nearly 0 C for several seconds. The temporary anesthesia is achieved at a fraction of the cost of EMLA cream (approximately US $0.50 per dose). The onset of action is nearly immediate. Flammability limits safe storage in some settings. A nonflammable related agent, Fluori-Methane (FM) (dichlorodifluoromethane and trichlorodifluoromethane, Gebauer Company, Cleveland, OH), was compared with EMLA cream in a pediatric trial and found to be equivalent with regard to pain reduction. 5,18 Two placebocontrolled trials confirmed the significant pain reduction provided by topical vapocoolants in routine childhood immunizations. 19,20 We evaluated the efficacy of FM in a randomized, placebo-controlled, single-blinded protocol, assessing pain reduction in adults receiving immunizations at an international travel clinic. Our secondary objective was to gauge participant preference for or against future use of topical vapocoolants. Methods Participants attending the International Travelers Health Clinic at the Cleveland Clinic Foundation were approached regarding their willingness to participate in this Institutional Review Board (IRB)-approved study. The informed consent document was explained, and willing participants were enrolled in the study. Patients were not enrolled if they had any known sensitivity to the topical vapocoolant, or were pregnant or breast-feeding. Only patients receiving two or more vaccinations were enrolled, in order to allow patients to serve as their own controls in assessing pain reduction. The randomization procedure was developed by the study statistician (KE) and administered by the data manager. A random permuted block algorithm was used to ensure balance between the number of patients assigned to each treatment and to each arm (right or left) and to make it difficult for study personnel to know where blocks started and stopped. The study design and data analysis followed the intent-to-treat principle. The sample size was determined using power calculations. The published efficacy of vapocoolant pain reduction is approximately 50%; 4,5 we used the conservative estimate of 25% efficacy to perform power calculations. Sample size calculations were estimated based on preliminary control data on pain scores (mean 3.0, and standard deviation 1.5). Assuming a change on average of 25% in pain scores from the vapocoolant group relative to the control group, a sample size of 90 per group (180 total) ensured 92% statistical power to detect a treatment difference of 0.75 points at a twosided 5% significance level if the true difference between treatments was 0.75 points. One hundred and eightyfive subjects greater than 18 years of age were randomly assigned to receive either the active agent (Fluori- Methane) or a placebo control (4 C; saline-wetted cotton ball). The randomization table indicated which arm (left or right) would receive the intervention (topical vapocoolant FM or placebo/control). The other arm received no additional treatment beyond routine sterility measures. The study was single-blinded. The participants were blinded as to which agent they received. Participants were the only ones involved in rating their pain. Since cooling is the mechanism of action known and described in the consent form, the placebo-controlled agent needed to be cold in order to provide equivalent comparison. Since topical vapocoolants may be perceived as colder than 4 C saline, individual participants received only one agent. To avoid bias created by the possibility of variable pain according to which vaccine was administered, specific vaccinations were given in the same arm for all participants whenever possible. Since pain is subjective, we constructed the study to allow participants to serve as their own controls, treating one arm prior to vaccination, and leaving the other untreated apart from routine antisepsis measures. Pain was rated for each arm separately, immediately and at 5 min. In order to standardize the data, we used a modified McGill present pain intensity (PPI) pain index preprinted scale for participants to rate their pain. Separate sheets were used to rate pain immediately and at 5 min. The patients were asked to rate their pain using either numerical analog estimates (0 to 10) or text (no pain to severe pain) scales. Aligning the numerical and text options resulted in a six-level scale. To accomplish the secondary objective, a six-question questionnaire was constructed. Each question allowed response
3 Mawhorter et al., Vapocoolants Quickly and Effectively Reduce Vaccine-associated Pain 269 along a five-level scale from 1 (strongly disagree) to 5 (strongly agree). Vaccination Vaccines were given according to standard package insert recommendations. Depending on the patients specific vaccines, care was taken to balance intramuscular and subcutaneous injections between arms whenever possible. Standard skin preparation involved the use of 70% v/v alcohol and was followed for all injections. Vapocoolant A sterile cotton ball was saturated with topical vapocoolant (FM) immediately before injection behind a cardboard screen to prevent the patient from seeing which agent was used. Placebo A participant randomized to the placebo/control group received a sterile cotton ball prewetted with sterile 4 C saline behind the same cardboard screen. The saturated cold cotton ball was applied to the injection site for 15 s,using firm pressure.the area was allowed to evaporate (1 to 2 s),the skin was cleansed with alcohol,and the injection was performed according to the package insert. Statistical Analysis Repeated measures analysis of pain scores was performed with a means model using SAS Proc Mixed software (version 8) providing separate estimates of the mean by treatment and time. Specifically, a linear model using restricted maximum likelihood estimation and a heterogeneous compound symmetry variance covariance form among the repeated measures was assumed for pain scores, and robust standard errors or parameters were used to perform statistical tests and construct 95% confidence intervals. Adjusted means and 95% confidence intervals, calculated by treatment group and time on study (immediate and 5 min), were used to summarize study results. The model-based means are unbiased with unbalanced and missing data, so long as the missing data are noninformative (missing at random). There were only 13 missing data points for the entire data set of 2,576 possible data entries, four in pain reporting and nine in the survey data. Similar analyses were performed separately for each arm. Statistical tests were two-sided. A p-value 0.05 was considered statistically significant. Results Background Characteristics One hundred and eighty-five subjects were enrolled. The ratio of male to female participants was 1.1 : 1. The median number of injections received per participant was three (mean 3.34; range 2 to 6). Efficacy Topical vapocoolant quickly and effectively reduced immediate vaccine pain (Fig. 1). The greatest, and hypothesis-expected, impact was on immediate pain. The graphic results show the mean of the pain index score and 95% confidence intervals for the participants comparing the standard preparation arm (No Rx) with the intervention arm (Rx). The topical vapocoolant significantly reduced immediate vaccine-associated pain compared to the untreated arm (p.001).pain index scores in the untreated left and right arms were very similar for both sides of the randomization, consistent with appropriately randomized groups (data not shown). The untreated (No Rx) pain index score mean in the FM randomized group 3.1 (95% CI %), whereas that of the untreated arm of the control randomized group (No Rx) 3.0 (95% CI %, p 0.50). The FMtreated immediate mean pain index score 2.2 (95% CI %), and the control agent immediate mean pain index score 2.8 (95% CI %). The comparison of these two groups at the immediate time point showed a statistically significant mean pain index score difference of 0.6 (95% CI %, p.01). A trend toward Figure 1 Effect of the topical vapocoolant Fluori-Methane on immediate vaccine-associated pain compared to placebo control. The graph shows mean and 95% confidence interval data for participants, comparing the untreated arm (No Rx) to the treated (Fluori-Methane or placebo/control) arm (Rx). Pain (y-axis) is measured using a modified McGill present pain intensity (PPI) pain index. Fluori-Methane resulted in a highly significant reduction in immediate pain compared to the untreated arm (p.001). There was a trend towards decreased pain among the treated arms of the placebo/control participants compared to their untreated arms (p.05). There was also a statistically significant difference between the pain reduction induced by the topical vapocoolant Fluori-Methane and that induced by the control agent (p.007).
4 270 Journal of Travel Medicine, Volume 11, Number 5 Figure 2 Effect of the topical vapocoolant Fluori-Methane compared to placebo control on immediate and 5-min vaccineassociated pain. The graph shows mean and standard deviation data for participants, comparing the treated (Fluori-Methane or placebo/control) arm (Rx) at immediate and 5-min time points. Pain (y-axis) is measured using a modified McGill present pain intensity (PPI) pain index. There was an additional decrease in pain in both groups over time, as expected. The statistically significant difference between the immediate pain reduction was lost by 5 min (p.32). decreased immediate pain among the saline control participants compared to the untreated arm was noted (mean 3.0 vs.2.8,p.05).the pain comparison between immediate and 5-min time points is graphically depicted in Figure 2. The pain reduction continued from the immediate to 5-min time points as expected. The mean pain level at 5 min was slightly less for topical vapocoolant group than for the placebo group (p.32). The FM 5-min mean pain index score 1.7 (95% CI %), and the control group 5-min mean pain index score 1.8 (95% CI %). The mean difference between the two groups at 5 min was 0.1 (95% CI , p.32).the untreated arm mean pain index for the FM group compared to that for the control group was 2.0 vs.1.9.at 5 min,there was a nonsignificant trend towards less pain in the arm that had received topical cold therapy than in the arm that had undergone standard prevaccination preparation (untreated arm) alone (p.05). Survey Results of Preference For or Against Future Topical Vapocoolant Use Survey results are plotted in Figure 3. Data represent the mean of the responses, with 3 being the middle, or no difference between choices, inflection point. There was no significant difference between the topical vapocoolant and placebo group responses for any of the questions. The standard error of the results was less than 0.5 for all groups across all questions. Neither group found the cold cotton ball therapy to be uncomfortable (question 1) or messy (question 3). Neither group preferred Figure 3 Questionnaire results document personal reactions and preferences regarding topical cold therapy. Responses to the first three questions are shown in (a), while responses to the last three questions are shown in (b). The range is from 1 (strongly disagree with the question) to 5 (strongly agree with the question), with 3 representing the middle or inflection point. There is no statistically significant difference in any of the responses between those using the topical vapocoolant Fluori- Methane and control respondents. Participants remained blinded to the agent received as they filled out their questionnaire. the injection alone without the cold cotton ball therapy. When asked if they would choose cold cotton ball therapy in the future (question 4), the majority of respondents indicated agreement. When given the hypothetical option of using cream to replace the cold cotton ball therapy, participants did not prefer this method of anesthetic application (question 5). Also, as seen in question 6, the 1-h wait for onset of efficacy of cream anesthetic would be highly inconvenient for our international travel clinic clients. Surveys were completed at the end of the visit, after participants had received their immunizations. Participants remained blinded to the agent they received when filling out the questionnaires. Discussion This study clearly shows the efficacy of the topical vapocoolant FM in significantly reducing immediate injection-associated pain among adult participants at an international travel clinic. Although the pain was similarly perceived at 5 min, the hypothesized point of pain
5 Mawhorter et al., Vapocoolants Quickly and Effectively Reduce Vaccine-associated Pain 271 reduction was expected to be immediate, given the pharmacodynamics of topical vapocoolants, and the pain dynamics of injection vaccines. 7 The trend towards sustained pain reduction at 5 min supports the benefit of this intervention for travel clients. Our results show an approximate 27% reduction in pain, validating our conservative study design to power the study at the 25% difference level. The lower level of pain reduction in this study compared to prior studies may be due to differences in pain perception in adults compared to children. 4,5 Pediatric studies use additional nonparticipant estimates of pain that may create differences when comparing our study to prior reports. The survey indicates a high degree of acceptance of this intervention. Anecdotally, participants returning for subsequent travel or booster injections were not reenrolled in the study, but many spontaneously asked for topical cold therapy for future injections. The reduction in pain with 4 C saline-wetted cotton balls was not unexpected. Original research into the threshold of pain reduction with topical vapocoolants indicates 10 C as the point at which pain reduction begins. 7,18 Our findings are also consistent with previous literature indicating greater pain reduction as skin temperature approaches 0 C. 5,7,18 20 The McGill PPI pain index has been validated in numerous studies. 21,22 It is able to differentiate between the discomfort felt as result of saline placebo injection, alum carrier injection and vaccines. 23 A study by Su et al. has even indicated a measurable difference in pain between the hepatitis A vaccines VAQTA (Merck) and HAVRIX (Glaxo SmithKline,Research Triangle Park,NC). 23 This information reinforces the validity of the use of this type of pain scale. A randomized control trial of the new combined hepatitis A and B vaccinations indicated excellent efficacy but slightly increased local pain associated with this vaccine compared to hepatitis B vaccination alone. 24 These data, and the general trend towards combination vaccines, make the use of a pain-reducing agent attractive to enhance acceptance. Development of the reliable, non-injection-based transdermal topical anesthetic EMLA (Eutectic Mixture of Local Anesthetics) was an important advance in the area of injection pain reduction. The oil-in-water emulsion enhances concentration of the anesthetics, facilitating absorption and penetration. 25 The combined inconvenience of cost (approximately US $5.00 to $7.50 per dose) and 60-min delay to onset of activity make this option poorly suited for use in the adult international travel immunization setting. This potential concern was confirmed in our survey results. A method involving the use of a mild electric current to reduce the time to onset of action of transcutaneously applied local anesthetics was developed and termed iontophoresis. 26 This method reduces the pain associated with some office injection procedures, but has not been studied for vaccine injections. 27 The advantage is reduction of the onset of action to 10 min.disadvantages include cost of the device (approximately $500), the medication cost (approximately US $5.00 to $7.50 per dose), and cumbersome application for multiple injections a common occurrence in the travel visit setting. 18 Jet injection delivery devices are equivalent in producing less anxiety and immediate pain,but lead to a significant increase in delayed local soreness and edema, which lasts longer than traditional needle injection discomfort. 28 There is also a history of rare infection transmission and blood on the nozzle surface, which is difficult to fully sterilize between vaccine recipients. 29 Newer versions use disposable nozzles and cartridges, yet retain the relatively high cost of the device (US $500 to 3000), limiting cost-effectiveness to very high volume settings. 18 Some may object to any intervention for vaccine recipients, given the nearly equivalent levels of pain reduction at 5 min after vaccination. However, pain is both personal and subjective. In this and other studies where patients preferences have been sought, several points stand out. First, participants prefer pain reduction whenever available. 8,18 Second, among the international travel clients of our study, there was a clear preference for the use of topical vapocoolant in the future, with no obvious detrimental responses. Third, cost and timeliness are significant factors in determining whether a given intervention will be widely useful and accepted. Fourth, this large randomized, prospective, single-blinded and adequately powered study confirms the effectiveness of FM in this setting. The disadvantages of vapocoolants are few. Application needs to be limited to 15 s, as longer times might produce uncomfortable local freezing of the skin. Ethyl chloride, used in older studies, is flammable. The agent of this study, FM, contains fluorocarbons. A new nonflammable, fluorocarbon-free compound is currently under development by the manufacturer. Preliminary data show a similar clinical profile to the current vapocoolant agents. Other factors favoring the use of FM include no reported history of allergy to the active ingredients, low cost, immediate onset of action, and flexibility. Since the vaccination needs of international travel clients can only be determined after specific review of individual itineraries, it is rarely possible to determine the number of injections that a person will actually need prior to evaluation at the travel consultation. Hence, an agent such as EMLA cream, which must be applied 60 min before vaccination, is not practical for use prior to the visit. Cost-effectiveness considerations favor an agent such as FM, which can be utilized for each injection, at the exact site immediately before vaccination.
6 272 Journal of Travel Medicine, Volume 11, Number 5 Conclusion Immunizations represent an important part of international travel preparation. Injection-associated pain is a reason why some travelers do not obtain all the recommended vaccinations. The immediate onset of action, significant efficacy and low cost make the topical vapocoolant FM an attractive agent worthy of consideration to reduce discomfort and facilitate vaccine acceptance at international travel preparation visits. Future studies with non-fluorocarbon-containing topical vapocoolants are planned. Acknowledgments Fluori-Methane was supplied by Gebauer Co. for use during the study without charge to the Cleveland Clinic Foundation. Declaration of Interests The authors had no financial or other conflicts of interest to disclose. References 1. World Tourism Organization.Available at: (accessed 30 June 2003). 2. World Tourism Organization. Available at: worldtourism.org/market_research/facts&figures/latest_data/ Mje.%20Highlights%202002%20INGLES.pdf (accessed 30 June 2003). 3. Centers for Disease Control and Prevention. Yellow book Available at: index.htm (accessed 30 June 2003). 4. Abbott K, Fowler-Kerry S. The use of a topical refrigerant anesthetic to reduce injection pain in children. J Pain Symptom Manage 1995; 10: Cohen Reis EC, Holubkov R. Vapocoolant spray is equally effective as EMLA cream in reducing immunization pain in school-aged children. Pediatrics 1997; 100(6):e5. 6. Yael N, Alona P, Edmond S, Israel P. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg 2003; 68: Travell J. Factors affecting pain of injection. JAMA 1955; 158: Jacobson RM, Swan A, Adegbenro A, et al. Making vaccines more acceptable methods to prevent and minimize pain and other common adverse events associated with vaccines. Vaccine 2001; 19: Bienvenu OJ, Eaton WW. The epidemiology of bloodinjection-injury phobia. Psychol Med 1998; 28: Hart PS, Yanny W. Needle phobia and malignant vasovagal syndrome. Anaesthesia 1998; 53: Braun MM, Patriarca PA, Ellenberg SS. Syncope after immunization. Arch Pediatr Adolesc Med 1997; 151: Wu LR, Parkerson GR Jr, Doralswamy PM. Health perception, pain, and disability as correlates of anxiety and depression symptoms in primary care patients. J Am Board Family Practice 2002; 15: Schultz AA, Strout TD, Jordan P, Worthing B. Safety, tolerability, and efficacy of iontophoresis with lidocaine for dermal anesthesia in ED pediatric patients. J Emerg Nurs 2002; 28: Krauss B, Green SM. Sedation and analgesia for procedures in children. N Engl J Med 2000; 342: Taddio A, Robieux I, Koren G. Effect of lidocaine prilocaine cream on pain from subcutaneous injection. Clin Pharmacol 1992; 11: Koren G. Use of the eutectic mixture of local anesthetics in young children for procedure-related pain. J Pediatr 1993; 122:S30 S Steward D. Eutectic mixture of local anesthetics (EMLA) what is it? What does it do? J Pediatr 1993; 122:S21 S Reis EC, Jacobson RM, Tarbell S, Weniger BG. Taking the sting out of shots: control of vaccination-associated pain and adverse reactions. Pediatr Ann 1998; 27: Eland JM. Minimizing pain associated with prekindergarten intramuscular injections. Issues Comprehens Pediatr Nurs 1981; 5: Maikler VE. Effects of a skin refrigerant/anesthetic and age on the pain responses of infants receiving immunizations. Res Nurs Health 1991; 14: McDowell I, Newell C. Pain measurement. In: McDowell I, Newell C, eds. Measuring health: a guide to rating scales and questionnaires, 2nd edn. New York: Oxford University Press, 1996: Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: Su L, Tucker R, Frey SE, et al. Measuring injection-site pain associated with vaccine administration in adults:a randomized, double-blind, placebo-controlled clinical trial. J Epidemiol Biostatistics 2000; 5: Bryan JP, McCardle P, South-Paul JE, et al. Randomized controlled trial of concurrent hepatitis A and B vaccination. Mil Med 2001; 166: Taddio A, Robieux I, Koren G. Effect of lidocaine prilocaine cream on pain from subcutaneous injection. Clin Pharmacol 1992; 11: Li LC, Scudds RA. Iontophoresis: an overview of the mechanisms and clinical application. Aruns Care Res 1995; 8: Maloney JM, Bezzant JL, Stephen RL, Petelenz TJ. Iontophoretic administration of lidocaine anesthesia in office practice. J Dermatol Surg Oncol 1992; 18: Parent du Chatelet I, Lang J, Schlumberger M, et al. Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Vaccine 1997; 15: Lindsay L. Assessing the safety of multidose jet injectors for the administration of vaccines. Thesis. Atlanta: Emory University, 1996.
Quality assessment No of patients Effect. Topical. Other considerations. serious 9 none 14/83 (16.9%)
Author(s): VS/AT Date: 2015-07-23 Question: Should topical anesthetics vs placebo/control be used for reducing vaccine injection pain in children 0-12 years? 1,2,3,4 Settings: clinics, schools Bibliography:
More informationIsaac Wiebe Medical Student C W Wiebe Medical Centre June & July 2015
Isaac Wiebe Medical Student C W Wiebe Medical Centre June & July 2015 Needlestick procedures Many interventions rely on needlestick procedures Venipuncture, intravenous cannulation, vaccination, lumbar
More informationDespite recent advances in the assessment and
Vapocoolant Is Equally Effective as Cream in Reducing Immunization Pain in School-aged Children Evelyn Cohen Reis, MD*, and Richard Holubkov, PhD ABSTRACT. Background. Untreated immunization pain causes
More informationA Randomized Clinical Trial of Vapocoolant for Pediatric Immunization Pain Relief
Georgia State University ScholarWorks @ Georgia State University Psychology Faculty Publications Department of Psychology 2009 A Randomized Clinical Trial of Vapocoolant for Pediatric Immunization Pain
More informationEffect of Topical Anesthetics on Needle Insertion Pain During Botulinum Toxin Type A Injections for Limb Spasticity
ORIGINAL ARTICLE Effect of Topical Anesthetics on Needle Insertion Pain During Botulinum Toxin Type A Injections for Limb Spasticity Sharon Fung, MD, Chetan P. Phadke, PhD, Alice Kam, MD, Farooq Ismail,
More informationGebauer Company History
Gebauer Company History The Gebauer Company was founded in 1899 by brothers Charles and Theophil Gebauer and was incorporated in 1902 as The Gebauer Chemical Company. Due to high demand by the healthcare
More informationResearch The effect of vapocoolant spray on pain due to intravenous cannulation in children: a randomized controlled trial
CMAJ JAMC Research The effect of vapocoolant spray on pain due to intravenous cannulation in children: a randomized controlled trial Ken J. Farion MD, Karen L. Splinter MD, Kym Newhook BScN RN, Isabelle
More informationImmunisations under sedation at a tertiary paediatric hospital in Melbourne, Australia from
Immunisations under sedation at a tertiary paediatric hospital in Melbourne, Australia from 2012-2016 Dr Kirsten Perrett Paediatrician, Royal Children s Hospital Melbourne NHMRC Research Fellow, Murdoch
More informationEACH year more than 10 million wounds are CLINICAL INVESTIGATIONS. LET versus EMLA for Pretreating Lacerations: A Randomized Trial
ACADEMIC EMERGENCY MEDICINE March 2001, Volume 8, Number 3 223 CLINICAL INVESTIGATIONS LET versus EMLA for Pretreating Lacerations: A Randomized Trial ADAM J. SINGER, MD, MARY JO STARK, RN Abstract. Objective:
More informationHAVRIX 1440 and HAVRIX Junior
HAVRIX 1440 and HAVRIX Junior Inactivated Hepatitis A Virus Vaccine Consumer Medicine Information Leaflet In this leaflet, HAVRIX refers to the use of both HAVRIX 1440 for adults and HAVRIX Junior for
More informationNew Medicines Profile
New Medicines Profile August 2008 Issue. 08/07 Lidocaine 70mg/tetracaine 70mg medicated plaster (Rapydan ) Concise evaluated information to support the managed entry of new medicines in the NHS Summary
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationLocal Anesthesia by Topical Application of Lidocaine After Stratum Corneum Ablation with an Er:YAG Laser
ISPUB.COM The Internet Journal of Anesthesiology Volume 6 Number 2 Local Anesthesia by Topical Application of Lidocaine After Stratum Corneum Ablation with an Er:YAG J Koh, D Harrison, S Flock, K Marchitto,
More informationProtocol. Title: The Effect of Needle Size on Pain Perception in Patients Treated with Botulinum Toxin A Injections
Protocol Title: The Effect of Needle Size on Pain Perception in Patients Treated with Botulinum Toxin A Injections Principal Investigator: Murad Alam, MD 1 Table of contents Table of contents List of abbreviations
More informationThe Effects of Nursing Intervention on Pain Control during Chemoport Needle Insertion
Vol.128 (Healthcare and Nursing 2016), pp.169-173 http://dx.doi.org/10.14257/astl.2016. The Effects of Nursing Intervention on Pain Control during Chemoport Needle Insertion Jin Hee Shin 1, Mee Lan Park²,
More informationStratis INSTRUCTIONS FOR USE. Needle-free Injection System. 0.5mL volume (+/-5%)
Stratis Needle-free Injection System INSTRUCTIONS FOR USE 0.5mL volume (+/-5%) Stratis English Symbols Glossary (Note: All symbols are derived from ISO 15223-1, Medical Devices - Symbols to be used with
More informationIs a Musical Intervention Effective In the Reduction of Needle Related Procedural Pain in Children?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 Is a Musical Intervention Effective In
More information5 $3 billion per disease
$3 billion per disease Chapter at a glance Our aim is to set a market size large enough to attract serious commercial investment from several pharmaceutical companies that see technological opportunites,
More informationMass Dispensing Operations. Lou Ann Lance, RN, MSN Public Health Emergency Epidemiology New York State Department of Health
Mass Dispensing Operations Lou Ann Lance, RN, MSN Public Health Emergency Epidemiology New York State Department of Health November 1, 2013 Participants will: Objectives Understand procedures for cold
More informationExpanded Programme on Immunization (EPI):
Expanded Programme on Immunization (EPI): Introduction Four to five million annual deaths could be prevented by 2015 through sustained and appropriate immunization efforts, backed by financial support.
More informationEvidence Based Medicine
Course Goals Goals 1. Understand basic concepts of evidence based medicine (EBM) and how EBM facilitates optimal patient care. 2. Develop a basic understanding of how clinical research studies are designed
More informationMedications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications
Patient Education Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications There are several medications for patients with MS that help slow the course of the
More informationSetting The setting was hospital. The economic analysis was conducted in Toronto, Montreal and Laval, Canada.
Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery Jewett M A, Valiquette L, Sampson H A, Katz J, Fradet Y, Redelmeier D A Record Status This is a critical
More informationModule 7: Case Discussion and Administration Technique
: Case Discussion and Administration Technique Miranda Wilhelm, Pharm.D. Clinical Associate Professor Department of Pharmacy Practice Southern Illinois University Edwardsville, School of Pharmacy 1 Disclosure
More informationControlled Test of the Analgesic and Relaxant Properties of Nitrous Oxide
Reprinted from the JOURNAL OF DENTAL RESEARCH, Vol. 53, No. 2, Pages: 486 490 g American Dental Association, 1974. All Rights Reserved. Controlled Test of the Analgesic and Relaxant Properties of Nitrous
More information2/25/18. Pain-free Procedures: Minimizing Discomfort in Procedures for Children. Inspiration. Trauma. Minimizing Pain. Outline
Pain-free Procedures: Minimizing Discomfort in Procedures for Children We have no relevant disclosures Peter A. Lio, MD Assistant Professor Clinical Dermatology & Pediatrics Northwestern University Feinberg
More informationInterventions for paediatric procedure-related pain in primary care
ORIGINAL ARTICLE Interventions for paediatric procedure-related pain in primary care Jill E MacLaren PhD 1, Lindsey L Cohen PhD 2 JE MacLaren, LL Cohen. Interventions for paediatric procedure-related pain
More informationTopical Local Anaesthesia
Topical Local Anaesthesia Comfort Kids Program 2017 Topical Local Anaesthesia (LA) How does topical LA cream works Misconceptions Cautions Preparation Application Alternatives Dosage Documentation Basic
More informationHealth Care Worker Vaccinations, 2011: EXTENDED CARE FACILITIES
Health Care Worker Vaccinations, 2011: EXTENDED CARE FACILITIES Karen K Hoffmann, RN, MS, CIC, FSHEA. Clinical Instructor, Division of Infectious Diseases University of North Carolina at Chapel Hill Associate
More informationVaccinating Adults: A Step-by-Step Guide
Vaccinating Adults: A Step-by-Step Guide step ₁ : getting started The Basics 1 6 Why the emphasis on adult vaccination? 3 How do I determine which vaccines adults need? 5 The Guide does not discuss vaccines
More informationQuestions and answers: HVTN 110 vaccine study
1. What is a vaccine study? A vaccine teaches the body to prevent a particular infection or fight a disease. In order to develop a vaccine, researchers need to test it in people. A vaccine study tests
More informationChapter 7. Principles of Pharmacology
Chapter 7 Principles of Pharmacology Introduction Administering medications is a serious business. Medications may alleviate pain and improve patient s well-being. Used inappropriately, may cause harm
More informationNORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
DECENBER 2011 NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Trigeminal
More informationMedical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health Authority
DNA Vaccines The Future of Travel Health Vaccines? Or Just a Bad Idea? Dr. Pierre J. Plourde Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health
More informationVACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES
VACCINE MANAGEMENT Recommendations for Handling and Storage of Selected Biologicals January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DTaP: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine
More informationHelp keep hepatitis A and B out of your travel plans.
Help keep hepatitis A and B out of your travel plans. Hepatitis A and B: Facts for Canadian travellers. Many common travel activities may put travellers at risk for hepatitis A and B. Hepatitis A and B
More informationHEPATYRIX (Combined inactivated hepatitis A and Vi polysaccharide typhoid vaccine) CONSUMER MEDICINE INFORMATION LEAFLET
HEPATYRIX (Combined inactivated hepatitis A and Vi polysaccharide typhoid vaccine) CONSUMER MEDICINE INFORMATION LEAFLET WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about
More informationvaccinators and criteria for pharmacist vaccinators
Appendix 4: Authorisation of vaccinators and criteria for pharmacist vaccinators Appendix 4: Authorisation of vaccinators and criteria A4.1 Protocol for authorisation of vaccinators and pharmacist vaccinators
More informationLana Hudanick RN, BSN Public Health Consultant Nurse Bureau of Immunization Assessment and Assurance Missouri Department of Health and Senior
Lana Hudanick RN, BSN Public Health Consultant Nurse Bureau of Immunization Assessment and Assurance Missouri Department of Health and Senior Services Identify the appropriate vaccines and the Advisory
More informationImmunization Dialogue
Immunization Dialogue Typhoid Vaccine Dr. T. Jacob John, Professor and Head, Department of Microbiology and Virology, Christian Medical College Hospital, Vellore, Tamil Nadu 632 004 answers important questions
More informationSome general information on hepatitis A infection is given at the end of this leaflet.
Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before
More informationTechniques. Alptekin Gursoy, Derun Taner Ertugrul, Mustafa Sahin, Neslihan Bascil Tutuncu, Asli Nar Demirer, and Nilgun Guvener Demirag
THYROID Volume 17, Number 4, 2007 ª Mary Ann Liebert, Inc. DOI: 10.1089=thy.2006.0326 Techniques Needle-Free Delivery of Lidocaine for Reducing the Pain Associated with the Fine-Needle Aspiration Biopsy
More informationCollecting Data Example: Does aspirin prevent heart attacks?
Collecting Data In an experiment, the researcher controls or manipulates the environment of the individuals. The intent of most experiments is to study the effect of changes in the explanatory variable
More informationAnnex II. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation
Annex II Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation 6 Scientific conclusions Overall summary of the scientific evaluation of EMLA cream and associated
More informationUnless there are complications, you should be able to return to your work the next day. The most common thing you may feel is sore back.
Sacroliac Joint Injection FAQ s: Will I be "put out" for this procedure? No. This procedure is done under local anesthesia. Most of the patients also receive intravenous sedation and analgesia, which makes
More informationReliability of Reported Age at Menopause
American Journal of Epidemiology Copyright 1997 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 146, No. 9 Printed in U.S.A Reliability of Reported Age at Menopause
More informationNANO 243/CENG 207 Course Use Only
L6. Drug Administration & Transport by Fluid Motion April 19, 2018 Part I: Drug Administration Routes of Drug Administration Topical: local effect, substance is applied directly where its action is desired.
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of COMBINED HEPATITIS A AND HEPATITIS B VACCINE TWINRIX PAEDIATRIC For Children aged 1 year to under 16 years TWINRIX ADULT For Adults and Adolescents
More informationPainless intravenous catheterization by intradermal jet injection of lidocaine: a randomized trial Zsigmond E K, Darby P, Koenig H M, Goll E F
Painless intravenous catheterization by intradermal jet injection of lidocaine: a randomized trial Zsigmond E K, Darby P, Koenig H M, Goll E F Record Status This is a critical abstract of an economic evaluation
More informationH1N1 Vaccine Administration Manual for Paramedics
H1N1 Vaccine Administration Manual for Paramedics TABLE OF CONTENTS I. Introduction II. Policy and Procedure for Administering Medications A. Intradermal B. Intramuscular C. Subcutaneous III. Pictorial
More informationGoal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84
Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care
More informationANESTHESIA FOR CHILDBIRTH
Southwest Ob / Gyn Associates, L.L.P 16651 Southwest Freeway, Suite 200 Sugar Land, TX 77479 7737 Southwest Freeway, Suite 895 Houston, TX 77074 Telephone: (713) 774-5131 Fax: (713) 774-4336 ANESTHESIA
More informationDr Olga Pleguezuelos CSO and Project Manager at SEEK
Dr Olga Pleguezuelos CSO and Project Manager at SEEK Imutex Limited, formed in 2016, is a joint venture between SEEK Group and hvivo to accelerate the development of a Mosquito Vaccine (AGS-v) and Broad-
More informationTopical EMLA Cream as a Pretreatment for Facial Lacerations
Topical EMLA Cream as a Pretreatment for Facial Lacerations Original Article Sung Woo Park, Tae Suk Oh, Jong Woo Choi, Jin Sup Eom, Joon Pio Hong, Kyung S Koh, Taik Jong Lee, Eun Key Kim Department of
More informationInfection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department
Infection Prevention and Control Annual Education 2017 Authored by: Infection Prevention and Control Department Objectives After you complete this Computer-Based Learning (CBL) module, you should be able
More informationSurgical Gown. A disposable gown worn by medical staff during surgery. A disposable gown worn by medical staff during surgery
Surgical Gown A disposable gown worn by medical staff during surgery Used by the surgeon during surgery; significant blood cover DOGS Surgical Gown A disposable gown worn by medical staff during surgery
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale
More informationThis vaccine is indicated for the prevention of poliomyelitis in infants, children and adults, for primary and booster vaccinations.
NAME OF THE MEDICINAL PRODUCT IMOVAX POLIO, suspension for injection in a prefilled syringe or multidose Poliomyelitis vaccine (inactivated) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (0.5 ml)
More informationModule 2: Vaccines and drugs: similarities and differences
Module 2: Vaccines and drugs: similarities and differences Vaccine PV Fellowship WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance Accra, Ghana 7 th 18 th September 2015 Learning
More informationCenter for Family Health Policy
Subject: Vaccine Management and Administration (Immunization) BOARD APPROVED: 7/30/96 REVISION APPROVED: 05/03/05, 04/08/08, 04/07/09, 04/12/11 Purpose: To ensure safe and appropriate storage, handling
More informationOREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS INACTIVATED JAPANESE ENCEPHALITIS VIRUS VACCINE
OREGON HEALTH AUTHORITY IMMUNIZATION PROTOCOL FOR PHARMACISTS INACTIVATED JAPANESE ENCEPHALITIS VIRUS VACCINE Update as of 06 2010 Addition of IXIARO, Inactivated, Adsorbed vaccine; grown in tissue culture
More informationMythbusters: No Pain, No Gain Managing Painful Pediatric Procedures. Vicki L. Sakata, MD
Mythbusters: No Pain, No Gain Managing Painful Pediatric Procedures Vicki L. Sakata, MD Objectives Identify myths regarding pediatric pain perception. Identify proper use and dosages of intranasal fentanyl
More information2014 OSHA Blood-borne Pathogens (BBP) Update JHS Annual Mandatory Education
2014 OSHA Blood-borne Pathogens (BBP) Update 2014 JHS Annual Mandatory Education Objectives Discuss the epidemiology of Bloodborne Pathogens. List the statistics of HIV/AIDS cases Identify the correlation
More information9.Pediatric Procedures
9.Pediatric Procedures A. Introduction 1. Pediatric blood collection may be by skin puncture or venipuncture. 2. Skill in pediatric phlebotomy is gained by knowledge of special collection equipment, observation
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Registration No.: 1C 10/54 (NBC) Importer / Manufacturer: MSD (Thailand) Ltd. / Merck Sharp & Dohme Corp., West Point, Pennsylvania 19486, USA SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL
More informationAn Open Randomized Study of Inactivated Hepatitis A Vaccine Administered Concomitantly with Typhoid Fever and Yellow Fever Vaccines
An Open Randomized Study of Inactivated Hepatitis A Vaccine Administered Concomitantly with Typhoid Fever and Yellow Fever Vaccines Elaine C. Jong, Karen M. Kaplan, Karen A. Eves, Colleen A.Taddeo, Hassan
More informationALVIMOPAN 0.0 OVERVIEW
ALVIMOPAN 0.0 OVERVIEW A. Alvimopan is a peripherally restricted mu-opioid receptor antagonist. B. DOSING INFORMATION : For the treatment of opioid bowel dysfunction, oral alvimopan doses between 0.5 milligrams
More informationPlacename CCG. Policies for the Commissioning of Healthcare
Placename CCG Policies for the Commissioning of Healthcare Policy for the funding of insulin pumps and continuous glucose monitoring devices for patients with diabetes 1 Introduction 1.1 This document
More informationComparison of Bier's Block and Systemic Analgesia for Upper Extremity Procedures: A Randomized Clinical Trial
J Arch Mil Med. 1 August; (3): e1977. Published online 1 August 3. DOI: 1.81/jamm.1977 Research Article Comparison of Bier's Block and Systemic Analgesia for Upper Extremity Procedures: A Randomized Clinical
More informationInsulin Delivery System and Self Monitoring Blood Sugar (SMBG ) Leyden V. Florido, RN, MAN
Insulin Delivery System and Self Monitoring Blood Sugar (SMBG ) Leyden V. Florido, RN, MAN Management of Diabetes Mellitus Pharmacological Glucose Lowering Agents/Oral Antidiabetes Drug/Oral Hypogycemic
More information1/6/18. Inspiration. Trauma. Pain-free Dermatology: Minimizing Discomfort in Procedures for Children and Adults. Minimizing Pain.
Pain-free Dermatology: Minimizing Discomfort in Procedures for Children and Adults I have no relevant disclosures Peter A. Lio, MD, FAAD Assistant Professor Clinical Dermatology & Pediatrics Northwestern
More informationMedicinal Product no longer authorised
MAJOR CHANGES 1 Procedural steps taken and scientific information after the authorisation Trudexa No Scope Opinion issued on Commission Decision II/0037 Update of of Characteristics To update section 5.1
More informationEMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin Injection A Randomized, Double-Blind, Placebo-Controlled Trial
Bahmani-Kashkouli et al EMLA Cream and Botulinum Toxin Iranian Journal of Ophthalmology - Volume 19, Number 4, 2007 EMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin
More informationGrowth Hormone plus Childhood Low- Dose Estrogen in Turner s Syndrome. N Engl J Med 2011;364: Present by R5 郭恬妮
Growth Hormone plus Childhood Low- Dose Estrogen in Turner s Syndrome N Engl J Med 2011;364:1230-42. Present by R5 郭恬妮 Introduction Turner s syndrome : partial or complete X-chromosome monosomy, 1 in 2000
More informationReduction of Pain and Anxiety Prior to Botulinum Toxin Injections With a New Topical Anesthetic Method
ORIGINAL ARTICLE Reduction of Pain and Anxiety Prior to Botulinum Toxin Injections With a New Topical Anesthetic Method Richard A. Weiss, M.D.*, and Phillip T. Lavin, M.D., Ph.D. *Weiss Cosmetic and Laser
More informationA Brief Guide to Writing
Writing Workshop WRITING WORKSHOP BRIEF GUIDE SERIES A Brief Guide to Writing Psychology Papers and Writing Psychology Papers Analyzing Psychology Studies Psychology papers can be tricky to write, simply
More informationNIH NEW CLINICAL TRIAL REQUIREMENTS AND FORMS-E
NIH NEW CLINICAL TRIAL REQUIREMENTS AND FORMS-E HOW DOES THE NIH DEFINE CLINICAL TRIAL AND HOW DO I KNOW IF MY STUDY IS ONE? 01-18-18 A clinical trial is defined by the NIH as a research study in which
More informationTrial No.: RIS-USA-102 Clinical phase: III
SYNOPSIS Trial identification and protocol summary Company: Johnson & Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica, N.V. Finished product: Risperdal Active ingredient:
More informationINSTRUCTIONS FOR USE
Comfort Injects 50 Comfort-in INSTRUCTIONS FOR USE English user manual 1 Introduction Thank you for choosing the Comfort in Needle free Injection system, developed with your comfort and convenience in
More informationGlobal Pulse Oximetry Project
3.3 Introduction of new health technologies: lessons learned Over the past twenty years there have been a number of comprehensive public health projects which illustrate important lessons regarding the
More informationDrew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax:
Dear Student, Enclosed you will find our policies, procedures and student consent form for your allergy immunotherapy. We ask that you read them carefully, sign the consent form, and take the physician
More informationManaging cost considerations and access to technology for cost effective vaccine manufacture in developing countries.
Managing cost considerations and access to technology for cost effective vaccine manufacture in developing countries. Amol R. Dindokar Serum Institute of India ltd. Overview Disease Control Priorities
More informationSUPPLEMENT ARTICLE METHODS
SUPPLEMENT ARTICLE Knowledge, Attitudes, and Practices Regarding Varicella Vaccination among Health Care Providers Participating in the Varicella Active Surveillance Project, Antelope Valley, California,
More informationSAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein
Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination
More informationEvaluation of a mass influenza vaccination campaign Takahashi H, Tanaka Y, Ohyama T, Sunagawa T, Nakashima K, Schmid G P, Okabe N
Evaluation of a mass influenza vaccination campaign Takahashi H, Tanaka Y, Ohyama T, Sunagawa T, Nakashima K, Schmid G P, Okabe N Record Status This is a critical abstract of an economic evaluation that
More informationTG4010. Public Information
TG4010 Public Information 11 May 2017 Public Information 11 May 2017 Page 2 /7 ABBREVIATIONS DNA Deoxyribonucleic acid GMO Genetically modified organism IL2 Interleukin-2 IM Intramuscular IT Intratumoral
More informationA single blind, randomised, 8 way crossover study to compare the blood volume and pain perception of capillary blood sampling
A single blind, randomised, 8 way crossover study to compare the blood volume and pain perception of capillary blood sampling There currently exist a plethora of single use blood sampling devices for obtaining
More informationAcute Pain Management in Children an update
Acute Pain Management in Children an update Frances W. Craig, MD FAAP East Tennessee Children s Hospital Overview Some pain basics Why we don t treat pain and why we should Non pharmacologic approaches
More informationEPIDEMIOLOGIC CHARACTERISTICS OF HEPATITIS A VIRUS INFECTIONS IN GREECE 1
AMERICAN JOURNAL OF EPIDEMIOLOGY Vol. 112, 4 Copyright 1980 by The Johns Hopkins University School of Hygiene and Public Health Printed in U.S-A. All rights reserved EPIDEMIOLOGIC CHARACTERISTICS OF HEPATITIS
More informationlozenge/spray) within the previous 8 hours; a longer acting or slow-release analgesic during the previous 24 hours (e.g. piroxicam, naproxen); any
Benzocaine: Primary: Chrubasik S, Beime B, Maora F. Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat. Eur Arch Otorhinolaryngol 2012; 269:571-77. Extended Abstract: Study
More informationUse of Subcutaneous Local Anaesthetic in Venous Catheters Channelling For Reducing Pain. Pedro Raúl Castellano Santana 1
International Journal of Nursing December 2015, Vol. 2, No. 2, pp. 179-186 ISSN 2373-7662 (Print) 2373-7670 (Online) Copyright The Author(s). 2015. All Rights Reserved. Published by American Research Institute
More informationClinical Study Synopsis for Public Disclosure
Clinical Study Synopsis for Public Disclosure These results are supplied for informational purposes only in the interest of scientific disclosure. The synopsis may include approved and non-approved uses,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P. Injectable, Suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:
More informationInterferential Current Therapy. Interferential current is essentially a deeper form of electrical stimulation
IFC Interferential current is essentially a deeper form of electrical stimulation In essence, IFC uses a carrier frequency, usually 4000 Hz and by crossing 2 individual current generators they interfere
More informationTYPHERIX PRODUCT INFORMATION (Salmonella typhi Vi polysaccharide)
TYPHERIX PRODUCT INFORMATION (Salmonella typhi Vi polysaccharide) DESCRIPTION TYPHERIX is a colourless, sterile liquid containing the cell surface Vi polysaccharide extracted from Salmonella typhi Ty2
More informationEfficacy of distraction on reduction of procedural pain associated with venipuncture in the pediatric post-cardiac transplant population
Efficacy of distraction on reduction of procedural pain associated with venipuncture in the pediatric post-cardiac transplant population Zoe Grabinski, MD, PGY-2 PI / Research Mentor: Daniel Tsze, MD,
More informationAn Industry- Biased Record
SSRI Use In Children: An Industry- Biased Record February 2004 By Merrill Goozner and Jeff DelViscio Tel: (202) 332-9110 Fax: (202) 265-4954 www.cspinet.org Suite 300 1875 Connecticut Avenue, NW Washington,
More informationSUMMARY THIS IS A PRINTED COPY OF AN ELECTRONIC DOCUMENT. PLEASE CHECK ITS VALIDITY BEFORE USE.
i SUMMARY ZENECA PHARMACEUTICALS FINISHED PRODUCT: ACTIVE INGREDIENT: ACCOLATE zafirlukast (ZD9188) Trial title (number): A Dose-ranging, Safety and Efficacy Trial with Zafirlukast (ACCOLATE ) in the Treatment
More informationTEST YOURSELF: Multiple Choice 1 QUESTIONS
1. In the investigation of an epidemic the most appropriate measure to describe the frequency of occurrence of illness is the: A. Prevalence B. Incidence rate C. Case-fatality rate D. Attack rate E. Mortality
More information